Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sven Detken"'
Autor:
Lena-Christin Conradi, Kathrin Stanek, Alexander Koenig, Claus Langer, Sven Detken, Tim Beissbarth, Markus Lowes, Rainer Lueck, Michael Ghadimi, Kia Homayounfar, Manuel Nietert, Mathias Kleiss
Publikováno v:
International Journal of Colorectal Disease
Purpose Multidisciplinary tumor boards (MDT) have been advocated as standard of care in modern oncology. German guidelines for metastasized colorectal cancer (mCRC) recommend MDT discussion of colon cancer patients after completion of primary tumor t
Autor:
Burkhard Schmidt, Lorenz Trümper, Detlef Haase, Sebastian Pfeiffer, Julie Schanz, Wolf-Karsten Hofmann, Ulrich Germing, Michael Lübbert, Richard F. Schlenk, Christina Ganster, Katayoon Shirneshan, Michael Metz, Katharina Götze, Gesine Bug, Michael B. Stadler, Tim H. Brümmendorf, Philippe Schafhausen, Kathleen Jentsch-Ullrich, Uwe Platzbecker, Angelika Böhme, Friederike Braulke, Sven Detken, Oliver G. Ottmann, Jörg Seraphin, Igor Wolfgang Blau, Catharina Müller-Thomas, Klaus Jung, Aristoteles Giagounidis
Publikováno v:
Leukemia Research. 37:900-906
The gold standard of cytogenetic analysis in myelodysplastic syndromes (MDS) is conventional chromosome banding (CCB) analysis of bone marrow (BM) metaphases. Most aberrations can also be detected by fluorescence-in situ-hybridization (FISH). For thi
Autor:
Lena-Christin Conradi, Kathrin Stanek, Tim Beissbarth, Markus Lowes, Sven Detken, Michael Ghadimi, Kia Homayounfar, Mathias Kleiss, Rainer Lueck, Manuel Nietert, Claus Langer
Publikováno v:
Journal of Clinical Oncology. 35:805-805
805 Background: Multidisciplinary Tumor Boards (MDT) have been advocated as standard of care in modern oncology. German cancer guidelines for metastasized colorectal cancer (mCRC) recommend discussing every patient (pt) with colon cancer (CC) after p
Autor:
Sven Detken, Hans-Jürgen Schulten, Jens Kuhlgatz, Florian Haller, László Füzesi, Bastian Gunawan, Nicole Happel
Publikováno v:
Annals of surgical oncology. 14(2)
In metastasized GISTs, resistance to imatinib after initial tumour response has been associated with observation of secondary mutations in the activation loop of KIT. The aim of the current study was to evaluate the tumour response and observance of
Autor:
Detlef Haase, Friederike Braulke, Philippe Schafhausen, Julie Schanz, Lorenz Trümper, Kathleen Jentsch-Ullrich, Gesine Bug, Uwe Platzbecker, Tim H. Brümmendorf, Sven Detken, Richard F. Schlenk, Christina Ganster, Michael Lübbert, Katharina Götze, Michael Metz, Catharina Müller-Thomas, Ulrich Germing, Wolf-Karsten Hofmann, Jörg Seraphin, Burkhard Schmidt, Klaus Jung, Oliver G. Ottmann, Igor Wolfgang Blau, Aristoteles Giagounidis, Michael Stadler, Angelika Böhme
Publikováno v:
Blood. 120:3816-3816
Abstract 3816 Background Conventional chromosome banding (CCB) analyses of bone marrow (bm) metaphases represent the gold standard of cytogenetic diagnostics in myelodysplastic syndromes (MDS), but they are not suitable for frequent follow-up analyse
Autor:
Katharina Götze, Lorenz Trümper, Ulrich Germing, Kathleen Jentsch-Ullrich, Sven Detken, Tim H. Brümmendorf, Friederike Braulke, Catharina Mueller-Thomas, Joerg Seraphin, Oliver G. Ottmann, Aristoteles Giagounidis, Michael Metz, Angelika Boehme, Gesine Bug, Detlef Haase, Philippe Schafhausen, Uwe Platzbecker, Julie Schanz
Publikováno v:
Blood. 116:2937-2937
Abstract 2937 Introduction: Chromosomal aberrations in myelodysplastic syndromes (MDS) play a major role in diagnostics, pathogenesis, prognosis, and, more recently, in treatment allocations. The acquisition of clonal abnormalities in pts with initia